Skip to main content

Table 4 PET-CT parameters and EC stage

From: Risk stratification of endometrial cancer and lymph node metastases prediction using 18F-FDG PET/CT: role of metabolic tumor volume and total lesion glycolysis

Parameter

Cases (%)

SUVmax

SUVmean

MTV

TLG

FIGO stage

IA

15 (45.5%)

12.75 ± 2.23

6.52 ± 1.79

19.95 ± 9.86

132.86 ± 84.91

 > IA

18 (54.5%)

20.77 ± 6.67

9.79 ± 2.89

38.49 ± 15.32

376.48 ± 202.22

P-value

 

0.0001

0.0006

0.0003

0.0001

95% CI

 

4.34 to 11.7

1.52 to 5.02

9.172 to 27.908

129.356 to 357.884